There are no published studies assessing the effects of GLP-1 medication microdosing, says Dr
Anyone considering either option should discuss risks, benefits, and suitability with a qualified healthcare provider
These risks and others described in the Risk Factors section of each of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and any of our subsequent filings with the Commission may not be exhaustive
With clear goals, close monitoring, and a plan for side effects and dose changes, some people can use these medicines safely
Its important to note that just four days ago, a paper in the American Journal of Ophthalmology found that there was no significant increase in risk of NAION or (ischemic optic neuropathy) in patients taking semaglutide or GLP-1 drugs compared to control group patients with Type 2 diabetes or high BMI
Semaglutide (Wegovy) Dosing Chart for Weight Loss: Benefits, Tips, and Dosage Explained Hey, Psst